Trials / Completed
CompletedNCT02281110
The REAL Registry for Utilization of iFR in Assessing Coronary Stenoses
A Prospective, Observational, Non-randomized European, Multi-center Registry Collecting Real Life Information for the Utilization of Instantaneous Wave Free Ratio in Assessing Coronary Stenosis Relevance in the Multi-vessel Disease Patients Population.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- Volcano Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this registry is to collect real life information and to document the performance and user friendliness of iFR in daily diagnostic practice and treatment strategies for MVD patients undergoing cardiac catheterization.
Detailed description
The REAL Registry will enroll a maximum of 3,000 patients in approximately 300 sites across multiple European and Middle East countries, where product has received CE approval and is marketed. An average of 10 cases with a maximum of 50 patients will be enrolled per participating site. No follow-up will be performed. The REAL Registry will only collect data during diagnostic angiogram or PCI procedure, when performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iFR/FFR | • The Volcano iFR®-FFR option, which is a measurement modality for the Volcano system that provides the capability to make FFR and instantaneous wave-Free Ratio™ (iFR®) measurements (CE-Marked). iFR® is a pressure-derived, hyperemia-free index for the assessment of coronary stenosis relevance. This option consists of an FFR-iFR® specific patient interface module (PIM-FFR) which can be connected to the Volcano system - VOLCANO s5 or s5i™ platform equipped with iFR® option. This PIM-FFR is compatible with all Volcano pressure measurement guide wires. |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-11-03
- Last updated
- 2016-05-10
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02281110. Inclusion in this directory is not an endorsement.